440 related articles for article (PubMed ID: 2528491)
1. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
2. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
3. Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments.
Serradas P; Bailbé D; Blondel O; Portha B
Pancreas; 1991 Jan; 6(1):54-62. PubMed ID: 1994380
[TBL] [Abstract][Full Text] [Related]
4. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
Dachicourt N; Bailbé D; Gangnerau MN; Serradas P; Ravel D; Portha B
Eur J Pharmacol; 1998 Nov; 361(2-3):243-51. PubMed ID: 9865514
[TBL] [Abstract][Full Text] [Related]
5. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
[TBL] [Abstract][Full Text] [Related]
6. Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model.
Tsuji K; Taminato T; Usami M; Ishida H; Kitano N; Fukumoto H; Koh G; Kurose T; Yamada Y; Yano H
Metabolism; 1988 Nov; 37(11):1040-4. PubMed ID: 3054430
[TBL] [Abstract][Full Text] [Related]
7. Impaired in vivo insulin secretion in response to non-glucidic secretagogues in adult rats after neonatal streptozotocin.
Vicent D; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ
Acta Diabetol; 1994 Sep; 31(3):133-7. PubMed ID: 7827350
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide.
van der Wal PS; Heine RJ
Diabetes Res Clin Pract; 2001 May; 52(2):103-11. PubMed ID: 11311964
[TBL] [Abstract][Full Text] [Related]
9. Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level.
Leahy JL; Weir GC
Diabetologia; 1991 Sep; 34(9):640-7. PubMed ID: 1955096
[TBL] [Abstract][Full Text] [Related]
10. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
[TBL] [Abstract][Full Text] [Related]
11. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
Inoue K; Hisatomi A; Umeda F; Nawata H
Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
[TBL] [Abstract][Full Text] [Related]
12. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
Sako Y; Grill VE
Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of glucose-induced insulin release during the spontaneous remission of streptozocin diabetes induced in the newborn rat.
Portha B; Kergoat M
Diabetes; 1985 Jun; 34(6):574-9. PubMed ID: 3891470
[TBL] [Abstract][Full Text] [Related]
14. Insulin treatment improves glucose-induced insulin release in rats with NIDDM induced by streptozocin.
Kergoat M; Bailbe D; Portha B
Diabetes; 1987 Aug; 36(8):971-7. PubMed ID: 3297892
[TBL] [Abstract][Full Text] [Related]
15. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats.
Ostenson CG; Efendic S; Grill V
Pancreas; 1990 May; 5(3):347-53. PubMed ID: 1971441
[TBL] [Abstract][Full Text] [Related]
16. New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats.
Abdelkader NF; Eitah HE; Maklad YA; Gamaleldin AA; Badawi MA; Kenawy SA
Life Sci; 2020 Apr; 247():117458. PubMed ID: 32092333
[TBL] [Abstract][Full Text] [Related]
17. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
Leahy JL; Bonner-Weir S; Weir GC
Diabetes; 1985 Jul; 34(7):660-6. PubMed ID: 2408948
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
[TBL] [Abstract][Full Text] [Related]
19. Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozocin as neonates.
Blondel O; Bailbé D; Portha B
Diabetes; 1989 May; 38(5):610-7. PubMed ID: 2523831
[TBL] [Abstract][Full Text] [Related]
20. Abnormal calcium handling by perifused pancreatic islets from neonatal streptozotocin diabetic model rats.
Hashimoto N; Kanatsuka A; Makino H; Sakurada M; Iwaoka H; Yoshida S; Horie H
Metabolism; 1987 Sep; 36(9):827-33. PubMed ID: 3306276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
